Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system

Journal of NeuroVirology

Volumn 10, Issue SUPPL. 1, 2004, Pages 15-20

  Barber, Sheila A ^a   Herbst, David S ^a   Bullock, Brandon T ^a   Gama, Lucio ^a   Clements, Janice E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CCAAT enhancer binding protein (C EBP) ; Dominant negative C EBP ; HIV; Interferon (IFN) ; SIV

Indexed keywords

BETA INTERFERON; CCAAT ENHANCER BINDING PROTEIN BETA; ISOPROTEIN; RECOMBINANT BETA INTERFERON; VIRUS DNA; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TYPE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DEMENTIA; DOWN REGULATION; DRUG MECHANISM; HOST RESISTANCE; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION RESISTANCE; INOCULATION; LONG TERMINAL REPEAT; MACACA; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INHIBITION; VIRUS TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 1542285320     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/753312747     Document Type: Article

References (36)

1. Abel K, Alegria-Hartman MJ, Rothaeusler K, Marthas M, Miller CJ (2002). The relationship between simian immunodeficiency virus RNA levels and the mRNA levels of alpha/beta interferons (IFN-alpha/beta) and IFN-alpha/beta-inducible Mx in lymphoid tissues of rhesus macaques during acute and chronic infection. J Virol 76: 8433-8445.
2. Barber SA, Bruett L, Douglass BR, Herbst DS, Zink MC, Clements J (2002). Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology. J Virol 76: 817-828.
3. Biron CA (2001). Interferons alpha and beta as immune regulators - a now look. Immunity 14: 661-664.
4. Brew BJ, Pemberton L, Cunningham P, Law MG (1997). Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 175: 963-966.
5. Clements JE, Babas T, Mankowski JL, Suryanarayana K, Piatak J, Tarwater PM, Lifson JD, Zink MC (2002). The CNS is a reservoir for SIV: steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis 186: 905-913.
6. Coyle-Rink J, Sweet T, Abraham S, Sawaya B, Batuman O, Khalili K, Amini S (2002). Interaction between TGF-beta signaling proteins and C/EBP controls basal and Tat-mediated transcription of HIV-1 LTR in astrocytes. Virology 299: 240-247.
7. Cremer I, Vieillard V, De Maeyer E (2000). Retrovirally mediated IFN-beta transduction of macrophages induces resistance to HIV, correlated with up-regulation of RANTES production and down-regulation of C-C chemokine receptor-5 expression. J Immunol 164: 1582-1587.
8. Davis LE, Hjelle BL, Miller VE (1992). Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42: 1736-1739.
9. Descombes P, Schibler U (1991). A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67: 569-579.
10. Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA (1997). Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group [see comments]. Ann Neurol 42: 679-688.
11. Flaherty MT, Hauer DA, Mankowski JL, Zink MC, Clements JE (1997). Molecular and biological characterization of a neurovirulent molecular clone of SIV. J Virol 71: 5790-5798.
12. Floris S, Ruuls SR, Wierinckx A, van der Pol SM, Dopp E, van der Meide PH, Dijkstra CD, De Vries HE (2002). Interferon-beta directly influences monocyte infiltration into the central nervous system. J Neuroimmunol 127: 69-79.
13. Giavedoni LD, Velasquillo MC, Parodi LM, Hubbard GB, Hodara VL (2000). Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol 74: 1648-1657.
14. Gold LH, Fox HS, Henriksen SJ, Buchmeier MJ, Weed MR, Taffe MA, Huitron-Resendiz S, Horn TF, Bloom FE (1998). Longitudinal analysis of behavioral, neurophysiological, viral and immunological effects of SIV infection in rhesus monkeys [In Process Citation]. J Med Primatol 27: 104-112.
15. Henderson AJ, Calame KL (1997). CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. Proc Natl Acad Sci USA 94: 8714-8719.
16. Hogan TH, Krebs FC, Wigdahl B (2002). Regulation of human immunodeficiency virus type 1 gene expression and pathogenesis by CCAAT/enhancer binding proteins in cells of the monocyte/macrophage lineage. J NeuroVirol 8(Suppl 2): 21-26.
17. Honda Y, Rogers L, Nakata K, Zhao BY, Pine R, Nakai Y, Kurosu K, Rom WN, Weiden M (1998). Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J Exp Med 188: 1255-1265.
18. Hoshino Y, Nakata K, Hoshino S, Honda Y, Tse DB, Shioda T, Rom WN, Weiden M (2002) Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J Exp Med 195: 495-505.
19. Hurtrel B, Chakrabarti L, Hurtrel M, Maire MA, Dormont D, Montagnier L (1991). Early SIV encephalopathy. J Med Primatol 20: 159-166.
20. Kim MO, Si Q, Zhou JN, Pestell RG, Brosnan CF, Locker J, Lee SC (2002). Interferon-beta activates multiple signaling cascades in primary human microglia. J Neurochem 81: 1361-1371.
21. Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD (1990). The role of interferons in the control of HIV replication in macrophages. Clin Immunol Immunopathol 54: 200-219.
22. Korth MJ, Taylor MD, Katze MG (1998). Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms. Virology 247: 265-273.
23. Lackner AA, Smith MO, Munn RJ, Martfeld DJ, Gardner MB, Marx PA, Dandekar S (1991). Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys. Am J Pathol 139: 609-621.
24. Ma Z, Qin H, Benveniste EN (2001). Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J Immunol 167: 5150-5159.
25. Mankowski JL, Flaherty MT, Spelman JP, Hauer DA, Didier PJ, Martin Amedee A, Murphey-Corb M, Kirstein LM, Munoz A, Clements JE, Zink MC (1997). Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol 71: 6055-6060.
26. McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER (1997). Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain [see comments]. Ann Neurol 42: 689-698.
27. Minagawa T, Mizuno K, Hirano S, Asano M, Numata A, Kohanawa M, Nakane A, Hachimori K, Tamagawa S, Negishi M, et al. (1989). Detection of high levels of immunoreactive human beta-1 interferon in sera from HIV-infected patients. Life Sci 45: iii-vii.
28. Murray EA, Rausch DM, Lendvay J, Sharer LR, Eiden LE (1992). Cognitive and motor impairments associated with SIV infection in rhesus monkeys. Science 255: 1246-1249.
29. Ossipow V, Descombes P, Schibler U (1993). CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc Natl Acad Sci USA 90: 8219-8223.
30. Prosch S, Heine AK, Volk HD, Kruger DH (2001). CCAAT/enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation. J Biol Chem 276: 40712-40720.
31. Sharer LR, Baskin GB, Cho ES, Murphey-Corb M, Blumberg BB, Epstein LG (1988). Comparison of Simian immunodeficiency virus and human immunodeficiency virus encephalitis in the immature host. Ann Neurol 23: S108-S112.
32. Weiden M, Tanaka N, Qiao Y, Zhao BY, Honda Y, Nakata K, Canova A, Levy DE, Rom WN, Pine R (2000). Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein beta expression. J Immunol 165: 2028-2039.
33. Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, Fu S, Pham T, Mei J, Ho JJ, Zhang W, Lopez P, Ho DD (2002). Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV activity of CD8 antiviral factor. Science 298: 995-1000.
34. Zink MC, Coleman GD, Mankowski JL, Adams RJ, Tarwater PM, Fox K, Clements JE (2001). Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis 184: 1015-1021.
35. Zink MC, Martin AA, Mankowski JL, Craig L, Munoz A, Didier P, Carter DL, Murphy-Corb M, Clements JE (1997). Pathogenesis of SIV encephalitis: selection and replication of neurovirulent SIV. Am J Pathol 151: 793-803.
36. Zink MC, Suryanarayana K, Mankowski JL, Shen A, Piatak J, Spelman JP, Carter DL, Adams RJ, Lifson JD, Clements JE (1999). High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol 73: 10480-10488.